Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

HIV treatment news

Show

From To
CytoDyn Announces HIV-Patients Approaching 17 Months of Complete Viral Suppression With PRO 140 Monotherapy

CytoDyn Inc. today announced that its study of a passive-antibody monotherapy, PRO 140, which is given as a weekly injection, has shown complete viral-load suppression for well over a year with some patients approaching 17 months. The Company believes that complete virologic suppression through treatment with a single agent rather than through the widely used HAART combination therapy could present a significant opportunity to treat HIV patients. CytoDyn is currently conducting a pivotal Phase 3 trial for PRO 140 with expected commercialization in 2017.

Published
27 January 2016
From
Cytodyn Inc.
Experimental Combination Surprises with Anti-HIV Effectiveness

A compound developed to protect the nervous system from HIV surprised researchers by augmenting the effectiveness of an investigational antiretroviral drug beyond anything expected. The potency of the combination treatment, tested so far in mice, suggests that it would be possible to rid the body of HIV for months, reducing the frequency with which patients must take these medications from daily to several times a year.

Published
27 January 2016
From
National Institute of Mental Health
People taking a large number of non-HIV-related medications more likely to stop or change HIV drugs

HIV-positive patients who are taking a large number of medications for the treatment of non-HIV-related conditions are at increased risk of stopping or changing their antiretroviral therapy (ART),

Published
27 January 2016
By
Michael Carter
Four Skills You Need to Successfully Manage Your HIV

Chronic illnesses can impact anyone, the secret is to manage yours. And to do that you need some specific skills. The people who are the most successful at managing their disease often do so by thinking of their illness as a journey or a hike down a path.

Published
24 January 2016
From
Huffington Post Canada
HIV/AIDS Guidelines App available for iOS and Android Devices

AIDSinfo is releasing a new HIV/AIDS Guidelines app for mobile devices. The AIDSinfo Guidelines app provides mobile access to the federally approved HIV/AIDS medical practice treatment guidelines. The guidelines include recommendations approved by expert panels on the treatment of HIV infection and related opportunistic infections in adults, adolescents, and children and on the management of perinatal HIV infection.

Published
24 January 2016
From
U.S. Food & Drug Administration (FDA)
IV and Injectable HIV Treatments Are Much Discussed -- But Won't Be Here Anytime Soon

Given the success of currently available oral therapies -- in which essentially 100% of people who take it are virologically suppressed -- why do so many people say they want injectable shots instead?

Published
21 January 2016
From
TheBody Pro
D:A:D study: long-term treatment with tenofovir associated with increased risk of serious liver disease

Long-term therapy with the antiretroviral drug tenofovir increases the risk of end-stage liver disease and liver cancer, according to data from the D:A:D study published

Published
21 January 2016
By
Michael Carter
NICE publishes new guideline to better tackle tuberculosis

NICE – the National Institute for Health and Care Excellence of England – published guidance on how to better treat and prevent tuberculosis. England has more TB cases than any other country in Western Europe.

Published
15 January 2016
From
NICE press release
Two cases of PrEP failure on solo tenofovir pose significant research questions

A report originally presented to the 2015 BHIVA conference last year details two cases where therapeutic levels of solo tenofovir unequivocally failed to prevent HIV infection in

Published
14 January 2016
By
Gus Cairns
Viread (Tenofovir, TDF) Linked With Liver Disease and Cancer

Long-term use of Viread (tenofovir disoproxil fumarate, or TDF) is associated with an increased risk of end-stage liver disease (ESLD) as well as hepatocellular carcinoma (HCC, the most common form of liver cancer) among people with HIV.

Published
14 January 2016
From
Poz

Filter by country